China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Wall Street
Price Targets
Price Targets Summary
China Resources Boya Bio pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 34.18 CNY with a low forecast of 30.3 CNY and a high forecast of 40.95 CNY.
Revenue
Forecast
Revenue Estimate
China Resources Boya Bio pharmaceutical Group Co Ltd
For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is 22%. The projected CAGR for the next 3 years is -4%.
Operating Income
Forecast
Operating Income Estimate
China Resources Boya Bio pharmaceutical Group Co Ltd
For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 12%.
Net Income
Forecast
Net Income Estimate
China Resources Boya Bio pharmaceutical Group Co Ltd
For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 41%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's stock price target?
Price Target
34.18
CNY
According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 34.18 CNY with a low forecast of 30.3 CNY and a high forecast of 40.95 CNY.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
-4%
For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is 22%. The projected CAGR for the next 3 years is -4%.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
12%
For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 12%.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
41%
For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 41%.